Yes, will be interesting but the unique thing with IHL though is that there is no existing pharma treatments for three of the clinical trial initiatives. No competitors.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks
CUF CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch
